These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35978777)

  • 21. Economic Policy Uncertainty and Family Firm Innovation: Evidence From Listed Companies in China.
    Qi Y; Dong S; Lyu S; Yang S
    Front Psychol; 2022; 13():901051. PubMed ID: 35774937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding East-West Cultural Differences on Perceived Compensation Fairness Among Executives: From a Neuroscience Perspective.
    Yu F; Zhao Y; Yao J; Farina Briamonte M; Profita S; Liu Y
    Front Psychol; 2021; 12():815641. PubMed ID: 35185709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RD internationalization, domestic technology alliance, and innovation in emerging market.
    Li J; Liu G; Ma Z
    PLoS One; 2021; 16(6):e0252669. PubMed ID: 34170909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining the Relationship Between Product Market Competition and Chinese Firms Performance: The Mediating Impact of Capital Structure and Moderating Influence of Firm Size.
    Mubeen R; Han D; Abbas J; Raza S; Bodian W
    Front Psychol; 2021; 12():709678. PubMed ID: 35662855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of digital transformation on innovation performance - The mediating role of innovation factors.
    Chen P; Kim S
    Heliyon; 2023 Mar; 9(3):e13916. PubMed ID: 36895347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualified foreign institutional investors and corporate innovation: From the perspective of corporate governance.
    Wang X; Wang W; Shi XY
    Front Psychol; 2022; 13():1005409. PubMed ID: 36467163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Mediating Role of Responsible Innovation in the Relationship between Stakeholder Pressure and Corporate Sustainability Performance in Times of Crisis: Evidence from Selected Regions in China.
    Tian H; Tian J
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do Returnee Executives Value Corporate Philanthropy? Evidence from China.
    Zhang L; Xu Y; Chen H
    J Bus Ethics; 2022; 179(2):411-430. PubMed ID: 34177016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corporate Social Responsibility Activities and Green Innovation Performance in Organizations: Do Managerial Environmental Concerns and Green Absorptive Capacity Matter?
    Mo X; Boadu F; Liu Y; Chen Z; Ofori AS
    Front Psychol; 2022; 13():938682. PubMed ID: 35874421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smog, media attention, and corporate social responsibility-empirical evidence from Chinese polluting listed companies.
    Xiong G; Luo Y
    Environ Sci Pollut Res Int; 2021 Sep; 28(34):46116-46129. PubMed ID: 33410010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Mixed-Ownership Reform on Innovation Performance of Manufacturing Companies: Evidence from China.
    Xia W; Chen X; Wang G
    Comput Intell Neurosci; 2022; 2022():3809829. PubMed ID: 35785061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key Subordinate Executive Governance, CEO Overconfidence, and Accounting Conservatism: From the Perspective of Sustainable Development.
    Wu F; Kuang X
    Front Psychol; 2021; 12():799221. PubMed ID: 35185696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-Firm Executive Mobility and Corporate Social Responsibility: Evidence From China.
    Wang J; Cao J
    Front Psychol; 2022; 13():904450. PubMed ID: 35719529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Specialized Knowledge Search on Enterprise Innovation.
    Liu X; Yao Z; Liu C; Zhao D; Lin C
    Front Psychol; 2021; 12():725514. PubMed ID: 34690884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of CEO Narcissism and Corporate R&D Investment.
    Wang L; Li H; Mu Y
    Front Psychol; 2022; 13():888618. PubMed ID: 35645881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of green innovation and environmental management on the environmental performance and value of a firm: an empirical study of energy-intensive listed companies in China.
    Yan X; Zhang Y
    Environ Sci Pollut Res Int; 2021 Jul; 28(27):35870-35879. PubMed ID: 33674978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic Policy Uncertainty, Environmental Regulation, and Green Innovation-An Empirical Study Based on Chinese High-Tech Enterprises.
    Zhu Y; Sun Z; Zhang S; Wang X
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do policy burdens induce excessive managerial perks? Evidence from China's stated-owned enterprises.
    Jian J; Li H; Meng L; Zhao C
    Econ Model; 2020 Aug; 90():54-65. PubMed ID: 32372842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoting and inhibiting: Corporate charitable donations and innovation investment under different motivation orientations--Evidence from Chinese listed companies.
    Wang H; Zhang Y; Tian M; Wang Z; Ding Y
    PLoS One; 2022; 17(4):e0266199. PubMed ID: 35417498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stock Market Liberalization and Corporate Green Innovation: Evidence from China.
    Zhang Y; Zhang J; Cheng Z
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33806099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.